The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Neuroinflammation in Alzheimer's disease and prion disease
Abstract
Alzheimer's disease (AD) and prion disease are characterized neuropathologically by extracellular deposits of Aβ and PrP amyloid fibrils, respectively. In both disorders, these cerebral amyloid deposits are co‐localized with a broad variety of inflammation‐related proteins (complement factors, acute‐phase protein, pro‐inflammatory cytokines) and clusters of activated microglia. The present data suggest that the cerebral Aβ and PrP deposits are closely associated with a locally induced, non‐immune‐mediated chronic inflammatory response. Epidemiological studies indicate that polymorphisms of certain cytokines and acute‐phase proteins, which are associated with Aβ plaques, are genetic risk factors for AD. Transgenic mice studies have established the role of amyloid associated acute‐phase proteins in Alzheimer amyloid formation. In contrast to AD, there is a lack of evidence that cytokines and acute‐phase proteins can influence disease progression in prion disease. Clinicopathological and neuroradiological studies have shown that activation of microglia is a relatively early pathogenetic event that precedes the process of neuropil destruction in AD patients. It has also been found that the onset of microglial activation coincided in mouse models of prion disease with the earliest changes in neuronal morphology, many weeks before neuronal loss and subsequent clinical signs of disease. In the present work, we review the similarities and differences between the involvement of inflammatory mechanisms in AD and prion disease. We also discuss the concept that the demonstration of a chronic inflammatory‐like process relatively early in the pathological cascade of both diseases suggests potential therapeutic strategies to prevent or to retard these chronic neurodegenerative disorders. GLIA 40:232–239, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 2×
“…for the classical NSAIDs that are known to inhibit both COX-1 and COX-2 but which have other, non-COX-mediated, modes of action, such as activation of nuclear receptor peroxisome proliferator-activated receptor- (PPAR ) and lowering A 42 production (Landreth et al., 2001; Weggen et al., 2001).”
BackgroundMcGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196 · cited 2×
“The idea that the neuroinflammatory response is an interesting therapeutic target for treatment with antiinflammatory drugs was also strongly supported by epidemiological studies showing that the use of classical NSAIDS can prevent or retard AD (McGeer et al., 1996; in t’ Veld et al., 2001).”
BackgroundIn-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.
Goldgaber, D., Harris, H. W., Hla, T., Maciag, T., Donnelly, R. J., Jacobsen, J. S., Vitek, M. P., & Gajdusek, D. C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7606 · Cited by 595
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
Brown, D. R., Schmidt, B., & Kretzschmar, H. A. (1996) · Nature · doi:10.1038/380345a0 · Cited by 502
Inflammation, autotoxicity and Alzheimer disease
McGeer, P. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00289-5 · Cited by 478
βA4 amyloid protein deposition in brain after head trauma
Roberts, G. W., Gentleman, S. M., Lynch, A., & Graham, D. I. (1991) · The Lancet · doi:10.1016/0140-6736(91)92724-g · Cited by 471
A randomized controlled trial of prednisone in Alzheimer’s disease
Aisen, P. S., Davis, K. L., Berg, J. D., Schafer, K., Campbell, K., Thomas, R. G., Weiner, M. F., Farlow, M. R., Sano, M., Grundman, M., et al. (2000) · Neurology · doi:10.1212/wnl.54.3.588 · Cited by 464
A randomized controlled trial of prednisone in Alzheimer’s disease
Koch, H. J., & Szecsey, A. (2000) · Neurology · doi:10.1212/wnl.55.7.1067 · Cited by 384
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro
Lue, L., Rydel, R., Brigham, E. F., Yang, L., Hampel, H., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 382
Prevention of Scrapie Pathogenesis by Transgenic Expression of Anti-Prion Protein Antibodies
Heppner, F. L., Musahl, C., Arrighi, I., Klein, M. A., Rülicke, T., Oesch, B., Zinkernagel, R. M., Kalinke, U., & Aguzzi, A. (2001) · Science · doi:10.1126/science.1063093 · Cited by 346
A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism
Kamboh, M. I., Sanghera, D. K., Ferrell, R. E., & DeKosky, S. T. (1995) · Nature Genetics · doi:10.1038/ng0895-486 · Cited by 336
Inflammatory mechanisms in Alzheimer's disease
Eikelenboom, P., Zhan, S.-S., van Gool, W. A., & Allsop, D. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90057-4 · Cited by 291
Self-citationRogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S.-S., Potter, H., & Nilsson, L. N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6421 · Cited by 290
BLASKO, I., MARX, F., STEINER, E., HARTMANN, T., & GRUBECK‐LOEBENSTEIN, B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.1.63 · Cited by 280
Jeffrey, M., Halliday, W. G., Bell, J., Johnston, A. R., Macleod, N. K., Ingham, C., Sayers, A. R., Brown, D. A., & Fraser, J. R. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00216.x · Cited by 262
Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain
Hoozemans, J. J. M., Rozemuller, A. J. M., Janssen, I., De Groot, C. J. A., Veerhuis, R., & Eikelenboom, P. (2001) · Acta Neuropathologica · doi:10.1007/s004010000251 · Cited by 246
Self-citationRole of microglia in neuronal cell death in prion disease
Giese, A., Brown, D. R., Groschup, M. H., Feldmann, C., Haist, I., & Kretzschmar, H. A. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00167.x · Cited by 239
Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice
Lim, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00299-8 · Cited by 227
Van Gool, W. A., Weinstein, H. C., Scheltens, P. K., & Walstra, G. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05623-9 · Cited by 212
Self-citationThe role of complement and activated microglia in the pathogenesis of Alzheimer's disease
Eikelenboom, P., & Veerhuis, R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00108-x · Cited by 206
Self-citationPrP Deposition, Microglial Activation, and Neuronal Apoptosis in Murine Scrapie
Williams, A., Lucassen, P. J., Ritchie, D., & Bruce, M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6424 · Cited by 204
Self-citationEVIDENCE FOR AN EARLY INFLAMMATORY RESPONSE IN THE CENTRAL NERVOUS SYSTEM OF MICE WITH SCRAPIE
BETMOUNI, S., PERRY, V. H., & GORDON, J. L. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00212-6 · Cited by 196
Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain
Shen, Y., Li, R., McGeer, E. G., & McGeer, P. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00850-0 · Cited by 195
McCusker, S. M., Curran, M. D., Dynan, K. B., McCullagh, C. D., Urquhart, D. D., Middleton, D., Patterson, C. C., McIlroy, S. P., & Peter Passmore, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04008-3 · Cited by 191
Papassotiropoulos, A., Bagli, M., Jessen, F., Bayer, T. A., Maier, W., Rao, M. L., & Heun, R. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<666::aid-ana18>3.0.co;2-3 · Cited by 186
Rozemuller, J. M., Eikelenboom, P., Pals, S. T., & Stam, F. C. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90547-8 · Cited by 173
Self-citationLandreth, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169
Characterization of the microglial response in murine scrapie
Williams, A. E., Lawson, L. J., Perry, V. H., & Fraser, H. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb00956.x · Cited by 151
Self-citationOka, A., & Takashima, S. (1997) · Neuroreport · doi:10.1097/00001756-199703240-00020 · Cited by 149
Microglia and the Immune Pathology of Alzheimer Disease
Giulian, D. (1999) · The American Journal of Human Genetics · doi:10.1086/302477 · Cited by 148
Microglia, amyloid and dementia in Alzheimer disease
Arends, Y. M., Duyckaerts, C., Rozemuller, J. M., Eikelenboom, P., & Hauw, J.-J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00094-4 · Cited by 139
Self-citationWilliams, A., van Dam, A., Ritchie, D. L., Eikelenboom, P., & Fraser, H. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00067-x · Cited by 138
Self-citationNilsson, L. N. G., Bales, K. R., DiCarlo, G., Gordon, M. N., Morgan, D., Paul, S. M., & Potter, H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01444.2001 · Cited by 137
Mabbott, N. A., Williams, A., Farquhar, C. F., Pasparakis, M., Kollias, G., & Bruce, M. E. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3338-3344.2000 · Cited by 126
Self-citationDie presbyophrene demenz, deren anatomische grundlage und klinische Abgrenzung
Fischer, O. I. (1910) · Zeitschrift für die gesamte Neurologie und Psychiatrie · doi:10.1007/bf02893605 · Cited by 125
Veerhuis, R., Van Breemen, M. J., Hoozemans, J. J., Morbin, M., Ouladhadj, J., Tagliavini, F., & Eikelenboom, P. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0624-7 · Cited by 123
Self-citationMicroglial cells respond to amyloidogenic PrP peptide by the production of inflammatory cytokines
Peyrin, J., Lasmézas, C. I., Haı̈k, S., Tagliavini, F., Salmona, M., Williams, A., Richie, D., Deslys, J., & Dormont, D. (1999) · Neuroreport · doi:10.1097/00001756-199903170-00012 · Cited by 115
Self-citationCytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice
Williams, A. E., van Dam, A., Man‐A‐Hing, W. K. H., BERKENBOSCH, F., Eikelenboom, P., & Fraser, H. (1994) · Brain Research · doi:10.1016/0006-8993(94)90480-4 · Cited by 101
Self-citationFraser, H., Brown, K., Stewart, K., McConnell, I., McBride, P., & Williams, A. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-8-1935 · Cited by 97
Self-citationPotter, H., Wefes, I. M., & Nilsson, L. N. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00308-6 · Cited by 90
Gentleman, S. M., Graham, D. I., & Roberts, G. W. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)63270-7 · Cited by 87
Van Muiswinkel, F. L., Veerhuis, R., & Eikelenboom, P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062468.x · Cited by 85
Self-citationDepressive Symptoms and Risk of Alzheimer's Disease in More Highly Educated Older People
Geerlings, M. I., Schmand, B. A., Braam, A. W., Jonker, C., Bouter, L. M., & van Tilburg, W. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04785.x · Cited by 82
Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain
Sasaki, A., Hirato, J., & Nakazato, Y. (1993) · Acta Neuropathologica · doi:10.1007/bf00369445 · Cited by 79
McBride, P., Wilson, M., Eikelenboom, P., TUNSTALL, A. M., & Bruce, M. E. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6740 · Cited by 74
Self-citationImmunological mechanisms and the spectrum of psychiatric syndromes in Alzheimer's disease
Eikelenboom, P., Hoogendijk, W. J. G., Jonker, C., & van Tilburg, W. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00006-7 · Cited by 73
Self-citationBetmouni, S., & Perry, V. H. (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00153.x · Cited by 50
Dapsone to delay symptoms in Creutzfeldt-Jakob disease
Manuelidis, L., Fritch, W., & Zaitsev, I. V. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79191-1 · Cited by 49
Killing of prion-damaged neurones by microglia
Bate, C., Reid, S. W. J., & Williams, A. (2001) · Neuroreport · doi:10.1097/00001756-200108080-00059 · Cited by 47
Self-citationVeerhuis, R., Hoozemans, J. J. M., Janssen, I., Boshuizen, R. S., Langeveld, J., & Eikelenboom, P. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03273-5 · Cited by 39
Self-citationDeslys, J. P., Lasmézas, C. I., de Villemeur, T. B., Jaegly, A., & Dormont, D. (1996) · PubMed · Cited by 31
Monocyte recruitment into the scrapie-affected brain
Williams, A. E., Ryder, S., & Blakemore, W. F. (1995) · Acta Neuropathologica · doi:10.1007/bf00294316 · Cited by 23
Self-citationImmunological Aspects of Alzheimer??s Disease: Therapeutic Implications
Hoozemans, J. J. M., Rozemüller, A. J. M., Veerhuis, R., & Eikelenboom, P. (2001) · BioDrugs · doi:10.2165/00063030-200115050-00004 · Cited by 21
Self-citationMicroglia and neurodegeneration
Rozemüller, A. J. M., & Muiswinkel, V. (2000) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2000.00665.x · Cited by 15
Cann, S. A. H., Netten, J. P. V., & Netten, C. V. (2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200003)47:3
Cited by
Immune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134
P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury
Tsuda, M., Shigemoto-Mogami, Y., Koizumi, S., Mizokoshi, A., Kohsaka, S., Salter, M. W., & Inoue, K. (2003) · Nature · doi:10.1038/nature01786 · Cited by 1,563
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Inflammation in neurodegenerative diseases
Amor, S., Puentes, F., Baker, D., & Van Der Valk, P. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03225.x · Cited by 1,355
Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury
Iliff, J. J., Chen, M. J., Plog, B. A., Zeppenfeld, D. M., Soltero, M., Yang, L., Singh, I., Deane, R., & Nedergaard, M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3020-14.2014 · Cited by 1,159
Metadata
- Authors
- Eikelenboom, P., Bate, C., Van Gool, W. A., Hoozemans, J. J. M., Rozemuller, J. M., Veerhuis, R., & Williams, A.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2002-10-04
- Volume
- 40
- Issue
- 2
- Pages
- 232-239
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2089701069
- Cited by
- 405
- References
- 63
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.